MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence

Large cell carcinoma (LCC) is a rare and aggressive lung cancer subtype with poor prognosis and no targeted therapies. Tumor-associated fibroblasts (TAFs) derived from LCC tumors exhibit premature senescence, and coculture of pulmonary fibroblasts with LCC cell lines selectively induces fibroblast s...

Descripción completa

Detalles Bibliográficos
Autores: Ikemori, Rafael, Llorente, A, Maqueda González, María de los Ángeles|||0000-0001-9304-1714, Dávalos Errando, Antoni, Perera Lluna, Alexandre|||0000-0001-6427-851X, Reguart, Noemí, Quiroz, Luis, Alcaraz Casademunt, Jordi
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universitat Politècnica de Catalunya (UPC)
Repositorio:UPCommons. Portal del coneixement obert de la UPC
Idioma:inglés
OAI Identifier:oai:upcommons.upc.edu:2117/345329
Acceso en línea:https://hdl.handle.net/2117/345329
https://dx.doi.org/10.1016/j.canlet.2021.01.028
Access Level:acceso abierto
Palabra clave:Lungs--Cancer
MMP1
Cancer-associated fibroblasts
SenescenceTGF-ß
Lung cancer
Pulmons -- Càncer
Àrees temàtiques de la UPC::Ciències de la salut
Descripción
Sumario:Large cell carcinoma (LCC) is a rare and aggressive lung cancer subtype with poor prognosis and no targeted therapies. Tumor-associated fibroblasts (TAFs) derived from LCC tumors exhibit premature senescence, and coculture of pulmonary fibroblasts with LCC cell lines selectively induces fibroblast senescence, which in turn drives LCC cell growth and invasion. Here we identify MMP1 as overexpressed specifically in LCC cell lines, and we show that expression of MMP1 by LCC cells is necessary for induction of fibroblast senescence and consequent tumor promotion in both cell culture and mouse models. We also show that MMP1, in combination with TGF-ß1, is sufficient to induce fibroblast senescence and consequent LCC promotion. Furthermore, we implicate PAR-1 and oxidative stress in MMP1/TGF-ß1-induced TAF senescence. Our results establish an entirely new role for MMP1 in cancer, and support a novel therapeutic strategy in LCC based on targeting senescent TAFs.